EMD-49222
Influenza A(H5N1) Clade 2.3.4.4b in complex with head specific monoclonal antibody NVX.361.4
EMD-49222
Single-particle3.38 Å
Deposition: 13/02/2025Map released: 30/07/2025
Last modified: 30/07/2025
Sample Organism:
H5N1 subtype,
unidentified influenza virus,
Mus musculus
Sample: Full-length recombinant A(H5N1) A/American Wigeon/South Carolina/22/000345-001/2021 (A/AW/SC/2021) clade 2.3.4.4b protein
Deposition Authors: Patel N
,
Rehman A ,
Gale S
Sample: Full-length recombinant A(H5N1) A/American Wigeon/South Carolina/22/000345-001/2021 (A/AW/SC/2021) clade 2.3.4.4b protein
Deposition Authors: Patel N
,
Rehman A ,
Gale S
Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin-Matrix-M ® nanoparticle vaccine induces neutralizing responses in nonhuman primates.
Patel N ,
Rehman A ,
Trost JF ,
Flores R,
Longacre Z,
Guebre-Xabier M,
Zhou H,
Zhou B,
Jacobson K,
Jiang D,
Bai X,
Khatoon R,
Kort T,
Norton J,
Madhangi M,
Hersey M,
Greene AM ,
Dubovsky F,
Smith G
(2025) Nat Commun , 16 , 6625 - 6625
,
Rehman A ,
Trost JF ,
Flores R,
Longacre Z,
Guebre-Xabier M,
Zhou H,
Zhou B,
Jacobson K,
Jiang D,
Bai X,
Khatoon R,
Kort T,
Norton J,
Madhangi M,
Hersey M,
Greene AM ,
Dubovsky F,
Smith G
(2025) Nat Commun , 16 , 6625 - 6625
Grant Support:
- Other private: Novavax, Inc. (United States)